EGFR and neoplasm: In fact, metastatic CRC (mCRC) was one of the first tumours in which precision medicine was implemented through hotspot KRAS‐NRAS gene sequencing due to its negative predictive value of response to anti‐Epidermal Growth Factor (anti‐EGFR) antibodies [4, 5].